Evidence map›Paper›PMID 26424587›Full record

Trial reportNutrition journal2015

The effect of melatonin treatment on postural stability, muscle strength, and quality of life and sleep in postmenopausal women: a randomized controlled trial.

Anne Kristine Amstrup, Tanja Sikjaer, Leif Mosekilde, Lars Rejnmark

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrition journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01690000 (Treatment of Osteopenia With Melatonin), which is not on this map. Cited by 26 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 3 pooled it
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01690000 nacompletednot on this map

Treatment of Osteopenia With Melatonin: Effects on BMD, Muscle Strength and Quality of Life

TypeinterventionalSponsorUniversity of AarhusRan2012 to 2014Enrolled81ConditionsOsteoporosisArmsMelatonin
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 3 syntheses or guidelines pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Melatonin and bone-related diseases: an updated mechanistic overview of current evidence and future prospects.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2023
    Review
  14. The association of melatonin use and hip fracture: a matched cohort study.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2023
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Anne Kristine AmstrupDepartment of Endocrinology and Internal Medicine (MEA), Aarhus University Hospital, Tage-Hansens Gade 2 DK-Aarhus C, 8000, Aarhus, Denmark. anne_kristine_am@hotmail.com.
Tanja SikjaerDepartment of Endocrinology and Internal Medicine (MEA), Aarhus University Hospital, Tage-Hansens Gade 2 DK-Aarhus C, 8000, Aarhus, Denmark.
Leif MosekildeDepartment of Endocrinology and Internal Medicine (MEA), Aarhus University Hospital, Tage-Hansens Gade 2 DK-Aarhus C, 8000, Aarhus, Denmark.
Lars RejnmarkDepartment of Endocrinology and Internal Medicine (MEA), Aarhus University Hospital, Tage-Hansens Gade 2 DK-Aarhus C, 8000, Aarhus, Denmark.
Aarhus University Hospital · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMelatonin is often used as a sleeping aid in elderly adults. As previous studies suggest a protective role of melatonin against osteoporosis, it is important to document its safety. Treatment should not cause any hangover effect that could potentially lead to falls and fractures. We therefore aimed to evaluate the effect of melatonin on balance- and muscle function. METHODS AND PATIENTS: In a double-blind placebo-controlled study, we randomized 81 postmenopausal women with osteopenia to receive 1 or 3 mg melatonin, or placebo nightly for 12 months. Postural balance as well as muscle function was measured. In addition, we assessed quality of life and sleep at baseline and after 12 months treatment.

resultsCompared to placebo, one-year treatment with melatonin did not affect postural balance or risk of falls. Furthermore, no significant changes between groups were observed in muscle strength in neither upper- nor lower extremities. Treatment did not affect quality of life or sleep. However, in the subgroup of women with sleep disturbances at baseline, a trend towards an improved sleep quality was seen (p = 0.08).

conclusionTreatment with melatonin is safe in postmenopausal women with osteopenia. There is no hangover effect affecting balance- and muscle function following the intake of melatonin. In women with a good quality of sleep, melatonin has no effect, however in poor quality of sleep, small doses of melatonin trended towards improving the quality.

trial registration(# NCT01690000).

Indexed as

Postural BalanceAgedBlood PressureBody Mass IndexDose-Response Relationship, DrugDouble-Blind MethodFemaleHumansMelatoninMiddle AgedMotor ActivityMuscle StrengthOsteoporosis, PostmenopausalPostmenopauseQuality of LifeSleepMelatonin

Identifiers

PMID26424587
PMCPMC4590707
OpenAlexW2120961824

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.